Welcome to LookChem.com Sign In|Join Free

CAS

  • or

374795-40-1

Post Buying Request

374795-40-1 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

374795-40-1 Usage

General Description

1-Oxa-9-azaspiro[5.5]undec-3-ene-9-carboxylic acid, 1,1-diMethylethyl ester is a chemical compound with the molecular formula C14H23NO3. It is commonly used as an ester in numerous industrial and research applications. 1-Oxa-9-azaspiro[5.5]undec-3-ene-9-carboxylic acid, 1,1-diMethylethyl ester is known for its spirocyclic structure, which contains an oxygen atom and a nitrogen atom in a fused ring system. 1-Oxa-9-azaspiro[5.5]undec-3-ene-9-carboxylic acid, 1,1-diMethylethyl ester has potential applications in pharmaceuticals, agrochemicals, and other fields based on its unique chemical properties. However, it is important to handle this compound with caution, as it may pose health and safety risks if not handled properly.

Check Digit Verification of cas no

The CAS Registry Mumber 374795-40-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,7,4,7,9 and 5 respectively; the second part has 2 digits, 4 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 374795-40:
(8*3)+(7*7)+(6*4)+(5*7)+(4*9)+(3*5)+(2*4)+(1*0)=191
191 % 10 = 1
So 374795-40-1 is a valid CAS Registry Number.

374795-40-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name tert-butyl 1-oxa-9-azaspiro[5.5]undec-3-ene-9-carboxylate

1.2 Other means of identification

Product number -
Other names 1-Oxa-9-azaspiro[5.5]undec-3-ene-9-carboxylic acid,1,1-dimethylethyl ester

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:374795-40-1 SDS

374795-40-1Relevant articles and documents

Nitroimidazole compound as well as preparation method and application thereof

-

Paragraph 0377-0379; 0384-0385, (2021/02/10)

The invention discloses a novel nitroimidazole compound as well as a preparation method and application thereof. The nitroimidazole compound has a general formula (I) shown in the specification.

Easy-To-Synthesize Spirocyclic Compounds Possess Remarkable in Vivo Activity against Mycobacterium tuberculosis

Guardia, Ana,Baiget, Jessica,Cacho, Mónica,Pérez, Arancha,Ortega-Guerra, Montserrat,Nxumalo, Winston,Khanye, Setshaba D.,Rullas, Joaquín,Ortega, Fátima,Jiménez, Elena,Pérez-Herrán, Esther,Fraile-Gabaldón, María Teresa,Esquivias, Jorge,Fernández, Raquel,Porras-De Francisco, Esther,Encinas, Lourdes,Alonso, Marta,Giordano, Ilaria,Rivero, Cristina,Miguel-Siles, Juan,Osende, Javier G.,Badiola, Katrina A.,Rutledge, Peter J.,Todd, Matthew H.,Remui?án, Modesto,Alemparte, Carlos

, p. 11327 - 11340 (2019/01/08)

Society urgently needs new, effective medicines for the treatment of tuberculosis. To kick-start the required hit-to-lead campaigns, the libraries of pharmaceutical companies have recently been evaluated for starting points. The GlaxoSmithKline (GSK) library yielded many high-quality hits, and the associated data were placed in the public domain to stimulate engagement by the wider community. One such series, the spiro compounds, are described here. The compounds were explored by a combination of traditional in-house research and open source methods. The series benefits from a particularly simple structure and a short associated synthetic chemistry route. Many members of the series displayed striking potency and low toxicity, and highly promising in vivo activity in a mouse model was confirmed with one of the analogues. Ultimately the series was discontinued due to concerns over safety, but the associated data remain public domain, empowering others to resume the series if the perceived deficiencies can be overcome.

Cyclohexane derivatives and their use as therapeutic agents

-

Page 36, (2010/02/06)

The present invention relates compounds of formula (I), wherein ring A is a phenyl or pyridyl ring; X represents a linker selected from the group consisting of formulae: (a), (b), (c), (d), and (e); and R1, R2, R3, R4, R5, R6, R7, R13, R14, R15, R16, R17, R21a and R21b are as defined herein. The compounds are of particular use in the treatment or prevention of depression, anxiety, pain, inflammation, migraine, emesis or postherpetic neuralgia.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 374795-40-1